Deferred Income Tax Expense (Benefit) in USD of JOHNSON & JOHNSON from 2009 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Johnson & Johnson quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2009 to Q1 2025.
  • Johnson & Johnson Deferred Income Tax Expense (Benefit) for the quarter ending March 30, 2025 was $2.17B.
  • Johnson & Johnson annual Deferred Income Tax Expense (Benefit) for 2024 was -$2.18B, a 47.9% increase from 2023.
  • Johnson & Johnson annual Deferred Income Tax Expense (Benefit) for 2023 was -$4.19B, a 152% decline from 2022.
  • Johnson & Johnson annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.66B, a 20% increase from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)

JOHNSON & JOHNSON Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $2.17B +$3.73B Dec 30, 2024 Mar 30, 2025 10-Q 2025-04-23
Q1 2024 -$1.56B -$19M -1.23% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-23
Q1 2023 -$1.54B -$617M -66.6% Jan 2, 2023 Apr 2, 2023 10-Q 2024-05-01
Q1 2022 -$926M -$196M -26.8% Jan 3, 2022 Apr 3, 2022 10-Q 2023-04-28
Q1 2021 -$730M -$784M -1452% Jan 4, 2021 Apr 4, 2021 10-Q 2022-04-29
Q1 2020 $54M +$416M Dec 30, 2019 Mar 29, 2020 10-Q 2021-04-30
Q1 2019 -$362M -$406M -923% Dec 31, 2018 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $1.9B Oct 1, 2018 Dec 30, 2018 10-K 2019-02-20
Q1 2018 $44M +$71M Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-01
Q1 2017 -$27M -$420M -107% Jan 2, 2017 Apr 2, 2017 10-Q 2018-05-01
Q1 2016 $393M -$152M -27.9% Jan 4, 2016 Apr 3, 2016 10-Q 2017-05-08
Q1 2015 $545M +$50M +10.1% Dec 29, 2014 Mar 29, 2015 10-Q 2016-05-10
Q1 2014 $495M +$130M +35.6% Dec 30, 2013 Mar 30, 2014 10-Q 2015-05-01
Q1 2013 $365M -$192M -34.5% Dec 31, 2012 Mar 31, 2013 10-Q 2014-05-02
Q1 2012 $557M +$561M Jan 2, 2012 Apr 1, 2012 10-Q 2013-05-03
Q1 2011 -$4M -$964M -100% Jan 3, 2011 Apr 3, 2011 10-Q 2012-05-07
Q1 2010 $960M Jan 4, 2010 Apr 4, 2010 10-Q 2011-05-10

JOHNSON & JOHNSON Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2.18B +$2.01B +47.9% Jan 1, 2024 Dec 29, 2024 10-K 2025-02-13
2023 -$4.19B -$2.53B -152% Jan 2, 2023 Dec 31, 2023 10-K 2025-02-13
2022 -$1.66B +$416M +20% Jan 3, 2022 Jan 1, 2023 10-K 2025-02-13
2021 -$2.08B -$938M -82.2% Jan 4, 2021 Jan 2, 2022 10-K 2024-02-16
2020 -$1.14B +$1.34B +53.9% Dec 30, 2019 Jan 3, 2021 10-K 2023-02-16
2019 -$2.48B -$1.46B -144% Dec 31, 2018 Dec 29, 2019 10-K 2022-02-17
2018 -$1.02B -$3.42B -142% Jan 1, 2018 Dec 30, 2018 10-K 2021-02-22
2017 $2.41B +$2.75B Jan 2, 2017 Dec 31, 2017 10-K 2020-02-18
2016 -$341M -$71M -26.3% Jan 4, 2016 Jan 1, 2017 10-K 2019-02-20
2015 -$270M -$711M -161% Dec 29, 2014 Jan 3, 2016 10-K 2018-02-21
2014 $441M +$1.05B Dec 30, 2013 Dec 28, 2014 10-K 2017-02-27
2013 -$607M -$568M -1456% Dec 31, 2012 Dec 29, 2013 10-K 2016-02-24
2012 -$39M +$797M +95.3% Jan 2, 2012 Dec 30, 2012 10-K 2015-02-24
2011 -$836M -$1.19B -335% Jan 3, 2011 Jan 1, 2012 10-K 2014-02-21
2010 $356M +$792M Jan 4, 2010 Jan 2, 2011 10-K 2013-02-22
2009 -$436M Dec 29, 2008 Jan 3, 2010 10-K 2012-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.